Bonus Episode: Diving into Menopausal HRT
In this bonus episode of the DUTCH podcast, Dr Jaclyn Smeaton continues her talk with Dr Anna Cabeca to tackle the often-overlooked subject of hormone replenishment during menopause.
Their conversation centres around comprehensive testing and the management of postmenopausal patients, with a particular focus on optimising the HPA axis.
Dr Cabeca shares insights into the precise procedures for testing women before initiating hormone replacement therapy, emphasising the significance of consistency in test timing.
This episode provides a valuable exploration of the important considerations for healthcare professionals and patients alike in hormone replenishment during menopause.
They discuss the importance of optimising the HPA axis and provide insights into accurate testing procedures while debunking common misconceptions about hormone therapies.
Share:
Related Posts
When Stress Affects Digestion (and Vice Versa): Restoring Balance Through Enzymes
2026 The connection between the brain and the digestive tract is anything but one-way. Practitioners have long observed that periods of stress often coincide with
What Is Insulin Resistance and Why Should I Know About It?
Written by Laura Kunces, PhD, RD, CSSD | 2026 It is estimated that 40% of adults in the United States ages 18-44 are insulin resistant,
Ashwagandha: An Ancient Herb for Modern Life with Kirsten Vaderhegghen
October 28 2025 • Thorne Trending wellness ideas with Kirsten Vaderhegghen, Thorne Medical Affairs Coordinator During this episode you’ll learn about: This week’s topic: Ashwagandha, an ancient
The Invisible Invader: Understanding Microplastics and How to Support Your Body’s Defense
Researched Nutritionals | 2026 What Are Microplastics and Where Do They Come From? Microplastics are plastic particles less than 5mm in length. This is roughly
Creatine 101: What It’s For, How to Use It, and Side Effects
Written by Joel Totoro, RD | 2025 Because athletes and bodybuilders are constantly looking for an edge to help their performance, it’s no surprise they